Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes
- 21 April 2000
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 35 (6) , 1434-1441
- https://doi.org/10.1016/s0735-1097(00)00597-0
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- ICD‐Antiarrhythmic Drug and ICD‐Pacemaker InteractionsJournal of Cardiovascular Electrophysiology, 1997
- Management of Patients With Atrial FibrillationCirculation, 1996
- The Treatment of Atrial FibrillationDrugs, 1994
- Effects of Procainamide and Lidocaine on Defibrillation Energy Requirements in Patients Receiving Implantable Cardioverter Defibrillator DevicesJournal of Cardiovascular Electrophysiology, 1994
- Effect of sotalol on ventricular fibrillation and defibrillation in humansThe American Journal of Cardiology, 1993
- DL and D Sotalol Decrease Defibrillation Energy RequirementsPacing and Clinical Electrophysiology, 1989
- Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillationThe American Journal of Cardiology, 1989
- Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillatorThe American Journal of Cardiology, 1987
- Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirementsJournal of the American College of Cardiology, 1986
- The implanted defibrillator: relation of defibrillating lead configuration and clinical variables to defibrillation thresholdJournal of the American College of Cardiology, 1985